Optimizing treatment for ovarian cancer using patient samples
Systems Oncology Approach to Optimize Ovarian Cancer Treatment
This study is trying to find better treatments for ovarian cancer by looking at samples from patients' tumors and blood to understand why some treatments don't work.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Sex | Female |
| Sponsor | University of Helsinki Academic / other |
| Locations | 1 site (Helsinki) |
| Trial ID | NCT06117384 on ClinicalTrials.gov |
What this trial studies
This observational study aims to identify effective therapeutic strategies for ovarian cancer by analyzing tumor, ascites, and blood samples from patients. It employs advanced sequencing techniques and functional assays to explore the mechanisms of chemoresistance in ovarian cancer. By systematically collecting and interpreting molecular, functional, and clinical data, the study seeks to uncover new treatment options for patients suffering from this condition.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with ovarian cancer who have available tumor tissue or blood samples.
Not a fit: Patients who are unable to consent to the study will not benefit from this research.
Why it matters
Potential benefit: If successful, this study could lead to more effective treatment strategies for ovarian cancer patients.
How similar studies have performed: Other studies utilizing similar biomolecular profiling approaches have shown promise in identifying effective treatments for various cancers.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients diagnosed with ovarian cancer * Available tumor tissue/blood samples Exclusion Criteria: * Inability to consent to the study
Where this trial is running
Helsinki
- Helsinki University and Helsinki University Hospital — Helsinki, Finland (Recruiting)
Study contacts
- Principal investigator: Anniina Färkkilä, MD PhD — Helsinki University Central Hospital
- Study coordinator: Anniina Färkkilä, MD PhD
- Email: anniina.farkkila@helsinki.fi
- Phone: +358504272060
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.